Valuation: InterCure Ltd.

Market Cap 143M 0 123M 115M 105M 197M 13.72B 200M 1.36B 529M 6.89B 538M 527M 22.79B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 280M 0 240M 224M 205M 385M 26.76B 390M 2.65B 1.03B 13.44B 1.05B 1.03B 44.47B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
60.83%
Yield 2024 *
-
Yield 2025 -
1 day+1.67%
1 week-6.89%
Current month-16.76%
1 month-7.02%
3 months+4.21%
6 months-6.09%
Current year-18.97%
1 week 251
Extreme 251
291.7
1 month 251
Extreme 251
315
Current year 225.3
Extreme 225.3
359
1 year 225.3
Extreme 225.3
570
3 years 225.3
Extreme 225.3
1,346
5 years 225.3
Extreme 225.3
2,635
10 years 146.83
Extreme 146.8255
6,317.95
Manager TitleAgeSince
Chief Executive Officer 55 2019-12-23
Director of Finance/CFO 47 2020-02-29
General Counsel - 2022-03-31
Director TitleAgeSince
Director/Board Member 50 2015-09-02
Director/Board Member 66 2014-12-13
Chairman 55 2025-02-12
Date Insider Type Main position Quantity % Market Cap.
3/18/26 Other

Director

15,000 0.0274%
11/9/22 Option

Chief Financial Officer

230,000 0.5066%
11/9/22 Option 230,000 0.5066%
Change 5-day change 1-year change 3-year change Capi.($)
+1.67%-6.89%-52.71%-53.40% 47.97M
+5.84%+7.51%-5.56%+197.92% 333M
+3.01%+1.18%-21.20%-15.76% 175M
+0.51%+0.51%+6.42%+84.26% 143M
+2.17%+11.90%-27.69%-14.55% 95.51M
0.00%+5.36%+13.46%+28.26% 53.07M
Average +2.20%+3.26%-14.55%+37.79% 141.13M
Weighted average by Cap. +3.34%+4.57%-10.74%+85.80%

Financials

2024 2025
Net sales 239M 0 205M 191M 175M 329M 22.85B 333M 2.26B 882M 11.48B 897M 877M 37.97B 270M 0 231M 217M 198M 372M 25.85B 377M 2.56B 998M 12.99B 1.01B 992M 42.96B
Net income -67.8M -0 -58.07M -54.34M -49.74M -93.35M -6.49B -94.58M -642M -250M -3.26B -255M -249M -10.78B -35.71M -0 -30.59M -28.62M -26.2M -49.17M -3.42B -49.82M -338M -132M -1.72B -134M -131M -5.68B
Net Debt 133M 0 114M 106M 97.4M 183M 12.7B 185M 1.26B 490M 6.38B 498M 488M 21.1B 136M 0 117M 109M 100M 188M 13.04B 190M 1.29B 503M 6.55B 512M 501M 21.67B
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
26-08-21 ILA 262.20 +1.67% 56,895
26-08-20 ILA 257.90 -2.86% 111,566
26-08-19 ILA 265.50 -6.28% 155,958
26-08-18 ILA 283.30 -0.49% 12,373
26-08-17 ILA 284.70 +1.10% 27,204
  1. Stock Market
  2. Stocks
  3. INCR Stock